Genome Sequencing Market Growth Through 2030 Creates New Strategic Opportunities
Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Genome Sequencing Market Growth Analysis: How Will Revenue Expand During The Forecast Period?
The genome sequencing market has experienced significant expansion in recent years, expanding from $11.78 billion in 2025 to $14.04 billion in 2026, representing a compound annual growth rate (CAGR) of 19.2%. Historical growth has been driven by limited access to sophisticated sequencing technologies, dependence on traditional Sanger sequencing methods, a rise in genomics research efforts, heightened government financial support for genome-related initiatives, and growing public awareness of personalized medicine.
Rapid expansion is anticipated for the genome sequencing market over the coming years, with projections indicating it will reach a valuation of $28.07 billion by 2030, representing a strong compound annual growth rate (CAGR) of 18.9%. Several factors are fueling this forecasted growth, including the development of advanced next-generation sequencing systems, the broadening of bioinformatics platforms, the increased uptake of precision medicine initiatives, and strengthened partnerships between biotechnology and pharmaceutical firms, alongside improvements in genomic data storage and management solutions. Key trends shaping the future landscape include a growing reliance on next-generation sequencing (NGS) methods, a heightened demand for personalized medicine and tailored therapies, an expansion of bioinformatics and analytical data services, a surge in environmental and microbiome genomics projects, and the incorporation of bespoke genome sequencing approaches into various applications.
Download A Free Sample Report For Comprehensive Market Insights:
Genome Sequencing Market Growth Drivers And Industry Catalysts
A rising incidence of cancer is anticipated to drive expansion in the genome sequencing market moving forward. Cancer encompasses a collection of diseases marked by the uncontrollable proliferation and spread of abnormal cells, which can result in fatality if left unmanaged. The prevalence of cancer is climbing due to various influences, such as an aging population, lifestyle choices, environmental contaminants, and inherited genetic tendencies. Through genome sequencing, it becomes possible to pinpoint genetic mutations and cancer vulnerabilities, facilitating early diagnosis and customized therapeutic approaches. This process reveals hereditary cancer risks and supports monitoring of cancerous cell progression. For example, in February 2024, the World Health Organization, an intergovernmental body based in Switzerland, reported that new cancer cases are forecasted to exceed 35 million by 2050, indicating a 77% rise from the 20 million cases recorded in 2022. Consequently, the growing frequency of cancer is fueling momentum in the genome sequencing market.
Genome Sequencing Market Segment Outlook: Which Categories Are Expanding The Fastest?
The genome sequencing market covered in this report is segmented –
1) By Product: Consumables, Systems And Software, Services
2) By Technology: Polymerase Chain Reaction (PCR), Sequencing, Microarray, Nucleic Acid Extraction, Purification, Other Technologies
3) By Applications: Diagnostics, Drug Discovery, Precision Medicine, Environmental Genomics, Research, Other Applications
4) By End-User: Hospitals And Clinics, Biotechnology And Pharmaceutical Companies, Contract Research Organizations (CROs), Government, Research Centers, Academic And Government Institutes, Other End-Users
Subsegments:
1) By Consumables: Reagents And Kits, Sequencing Chips And Plates, Sample Preparation Products, Library Preparation Kits, DNA And RNA Extraction Kits
2) By Systems And Software: Next-Generation Sequencing (NGS) Systems, Sanger Sequencing Systems, Bioinformatics Software And Analysis Tools, Data Management And Storage Solutions, Laboratory Information Management Systems (LIMS)
3) By Services: Sequencing Services, Bioinformatics Analysis Services, Consultation And Support Services, Custom Genome Sequencing Solutions, Sample Collection And Preparation Services.
Genome Sequencing Market Trends Influencing Long-Term Demand
Major players in the genome sequencing market are concentrating on creating cutting-edge solutions, like next-generation sequencing (NGS)-based assays, to improve the precision of genetic analysis and support personalized medicine strategies. These NGS-based assays represent sophisticated genomic tools that enable fast, high-throughput sequencing of DNA or RNA for genetic material examination. By allowing the simultaneous sequencing of millions of DNA or RNA fragments, NGS generates substantial data volumes quickly and at reduced costs. For example, in April 2023, Centogene N.V., a German firm specializing in genetic diagnostics for rare diseases, introduced CentoGenome, an enhanced NGS-based assay. This solution provides lifelong diagnostic support through proactive confirmation and reclassification programs at no additional charge, ensuring ongoing patient care and accurate disease management. Employing a PCR-free method, CentoGenome minimizes bias and improves sequencing quality, delivering superior coverage of challenging genomic regions and deeper insights into coding, regulatory, and intronic areas. The platform incorporates an automated bioinformatics pipeline and expert medical analysis, leveraging CENTOGENE’s extensive biodatabank with data from roughly 700,000 patients across over 120 countries. This comprehensive dataset enhances the detection of disease-causing variants, including those linked to spinal muscular atrophy and Parkinson’s disease.
Genome Sequencing Market Key Companies And Competitive Benchmarking
Major companies operating in the genome sequencing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers, Becton Dickinson and Company, Eurofins Genomics, Agilent Technologies Inc., PerkinElmer, Illumina Inc., bioMérieux, Bio-Rad Laboratories Inc., QIAGEN N.V., 10x Genomics Inc., BGI Group, Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., GENEWIZ Inc., LI-COR Inc., CENTOGENE N.V., Bioneer Corporation, Strand Life Sciences Pvt Ltd., Nebula Genomics
Access The Complete Genome Sequencing Market Report:
Genome Sequencing Market Global Footprint: Which Region Holds Market Leadership?
North America was the largest region in the genome sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genome sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
